DSpace Home
→
Araştırma Çıktıları / Research Outputs
→
WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection
→
Browsing WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection by Author

Browsing WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection by Author "Yaldiz, Mahizer"

Now showing items 1-6 of 6

An extensive pyoderma gangrenosum mimicking necrotizing fasciitis: An unusual case report

Aziret, Mehmet; Kara, Seyma; Yaldiz, Mahizer; Kose, Nur; Asikuzunoglu, Feyza; Cevrioglu, Arif Serhan (ELSEVIER SCI LTD, 2021)

INTRODUCTION: Pyoderma Gangrenosum (PG) is a rare, benign and inflammatory disease characterized by ulcerative skin lesions. We report the successful management of an unusual case of PG following a caesarean section, with ...
Assessment of auditory function and lipid levels in patients receiving oral isotretinoin (13-cis retinoid) therapy for acne vulgaris

Yaldiz, Mahizer; Kara, Ahmet; Guven, Mehmet; Solak, Berna; Kara, Rabia; Erdem, Mustafa Teoman (TERMEDIA PUBLISHING HOUSE LTD, 2020)

Introduction: Isotretinoin (13-cis retinoid) is a synthetic retinoid. It was approved by the FDA in 1982 for use of oral isotretinoin in severe acne. It is also used in moderate-severe acne that does not respond to ...
Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris

Cosansu, Nur Cihan; Yuksekal, Gulcan; Turan, Ulku; Umitfer, Fulya; Yaldiz, Mahizer; Dikicier, Bahar Sevimli (2022)

Purpose Oral isotretinoin (ISO) can effect markers of inflammation in patients with acne vulgaris. Systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) were described as novel inflammatory ...
New markers to predict the response to omalizumab in chronic spontaneous urticaria

Cosansu, Nur Cihan; Kara, Rabia Oztas; Yaldiz, Mahizer; Dikicier, Bahar Sevimli (2022)

Omalizumab has high treatment efficacy in patients with chronic spontaneous urticaria (CSU) who do not respond to high doses of antihistamines. Systemic immune-inflammation index (SII) and systemic inflammation response ...
Omalizumab treatment for chronic spontaneous urticaria: data from Turkey

Kara, Rabia Oztas; Dikicier, Bahar Sevimli; Yaldiz, Mahizer; Koku, Busra; Cosansu, Nur Cihan; Solak, Berna (TERMEDIA PUBLISHING HOUSE LTD, 2022)

Aim: The aim of the study was to investigate data from patients suffering from chronic spontaneous urticaria refractory to conventional therapy, and to document outcomes of omalizumab use. Material and methods: We conducted ...
The change in the frequency and severity of facial dermatoses and complaints in healthcare workers during the COVID-19

Cosansu, Nur Cihan; Yuksekal, Gulcan; Kutlu, Omer; Umaroglu, Mutlu; Yaldiz, Mahizer; Dikicier, Bahar Sevimli (WILEY, 2022)

Background The coronavirus disease 2019 (COVID-19) pandemic has led to a dramatic increase in the use of personal protective equipment (PPE). However, the increased use of PPEs may lead to facial skin complaints. Aims This ...